There was a trend toward younger age at diagnosis among patients with multilineage SF3B1 mutations (mean age 65.8 years) compared to patients with BM-restricted mutations (mean age 70.4 years), but the difference did not reach statistical significance.
← all excerpts
Different <i>SF3B1</i> Mutation Hotspots Show Hematopoietic Lineage-Specific VAF Patterns and Correlate with Distinct Genetic and Prognostic Profiles in Patients with Myeloid Neoplasms.
1
—
—